HGMI Health: A Leader in Global Pharmaceutical Development

Addressing the Challenges of Drug Loss and Drug Lag

In pharmaceutical development, the shift from country-specific development to global development has become an irreversible trend. However, issues such as “drug loss” and “drug lag” continue to have a serious impact on patients and healthcare systems across different countries. Given the diversity of systems, historical contexts, and cultural backgrounds, introducing a uniform solution worldwide is not a realistic option.

Strategic Approaches to Japan’s Market Strengths and Challenges

Japan remains one of the largest pharmaceutical markets in the world. At the same time, due to its geographical position and ethnic characteristics, drug metabolism and safety profiles often differ from those in Western populations. Consequently, Japanese authorities must take a more cautious approach to the review process, which can contribute to longer approval timelines.

At HGMI Health, we do not attempt to alter these unique conditions. Instead, our team of experts—well-versed in both Japanese and Western regulatory environments and cultural contexts—provides the most efficient and strategic approach to global development.

Driving Your Success and Accelerating Global Launch

HGMI Health’s knowledge and extensive experience in international joint development will steadily guide your new drug programs toward success. We are committed to helping you bring safe and effective medicines to patients around the world as quickly as possible.

Contact Us

Please feel free to reach out to us at any time.

HGMI Health is your trusted partner in global pharmaceutical development.